Nomura Holdings, Inc. - Net Worth and Insider Trading

Nomura Holdings, Inc. Net Worth

The estimated net worth of Nomura Holdings, Inc. is at least $27 Million dollars as of 2024-06-23. Nomura Holdings, Inc. is the 2201 Interest of corporation controlled by you of Kintor Pharmaceutical Ltd and owns about 24,212,545 shares of Kintor Pharmaceutical Ltd (HKSE:09939) stock worth over $27 Million. Details can be seen in Nomura Holdings, Inc.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Nomura Holdings, Inc. has not made any transactions after 2023-06-05 and currently still holds the listed stock(s).

Transaction Summary of Nomura Holdings, Inc.

To

Nomura Holdings, Inc. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Nomura Holdings, Inc. owns 1 companies in total, including Kintor Pharmaceutical Ltd (HKSE:09939) .

Click here to see the complete history of Nomura Holdings, Inc.’s form 4 insider trades.

Insider Ownership Summary of Nomura Holdings, Inc.

Ticker Comapny Transaction Date Type of Owner
HKSE:09939 Kintor Pharmaceutical Ltd 2023-06-05 2201 Interest of corporation controlled by you

Nomura Holdings, Inc. Latest Holdings Summary

Nomura Holdings, Inc. currently owns a total of 1 stock. Nomura Holdings, Inc. owns 24,212,545 shares of Kintor Pharmaceutical Ltd (HKSE:09939) as of June 5, 2023, with a value of $27 Million.

Latest Holdings of Nomura Holdings, Inc.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HKSE:09939 Kintor Pharmaceutical Ltd 2023-06-05 24,212,545 1.10 26,633,800

Holding Weightings of Nomura Holdings, Inc.


Nomura Holdings, Inc. Form 4 Trading Tracker

According to the SEC Form 4 filings, Nomura Holdings, Inc. has made a total of 6 transactions in Kintor Pharmaceutical Ltd (HKSE:09939) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Kintor Pharmaceutical Ltd is the sale of 2,528,500 shares on June 5, 2023, which brought Nomura Holdings, Inc. around $0.

Insider Trading History of Nomura Holdings, Inc.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Nomura Holdings, Inc. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Nomura Holdings, Inc. Ownership Network

Ownership Network List of Nomura Holdings, Inc.

No Data

Ownership Network Relation of Nomura Holdings, Inc.

Insider Network Chart

Nomura Holdings, Inc. Owned Company Details

What does Kintor Pharmaceutical Ltd do?

Who are the key executives at Kintor Pharmaceutical Ltd?

Nomura Holdings, Inc. is the 2201 Interest of corporation controlled by you of Kintor Pharmaceutical Ltd. Other key executives at Kintor Pharmaceutical Ltd include 2101 Beneficial owner Tong Youzhi , 2101 Beneficial owner Kt International Investment Limited , and 2201 Interest of corporation controlled by you Guo Chuangxing .

Kintor Pharmaceutical Ltd (HKSE:09939) Insider Trades Summary

Over the past 18 months, Nomura Holdings, Inc. made 6 insider transaction in Kintor Pharmaceutical Ltd (HKSE:09939) with a net sale of 0. Other recent insider transactions involving Kintor Pharmaceutical Ltd (HKSE:09939) include a net sale of 11,530,471 shares made by Guo Chuangxing , a net sale of 11,530,471 shares made by Kg Development Limited , and a net purchase of 500,000 shares made by Tong Youzhi .

In summary, during the past 3 months, insiders sold 0 shares of Kintor Pharmaceutical Ltd (HKSE:09939) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 24,201,000 shares of Kintor Pharmaceutical Ltd (HKSE:09939) were sold and 2,140,058 shares were bought by its insiders, resulting in a net sale of 22,060,942 shares.

Kintor Pharmaceutical Ltd (HKSE:09939)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Kintor Pharmaceutical Ltd Insider Transactions

No Available Data

Nomura Holdings, Inc. Mailing Address

Above is the net worth, insider trading, and ownership report for Nomura Holdings, Inc.. Currently GuruFocus does not have mailing address information for Nomura Holdings, Inc..

Discussions on Nomura Holdings, Inc.

No discussions yet.